The Impact of COVID‐19 Pandemic on Respiratory Syncytial Virus Infection in Children
Pulmonary Medicine · 2024-01 · 2024 (1)
DOI: 10.1155/2024/2131098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pulmonary Medicine, online erschienen am 18.10.2024. Verfasst von Jose Boris Trigueros Montes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Flushing Hospital Medical Center, Flushing, New York 11355, USA. Hauptthemen laut MEDLINE: COVID-19, Respiratory Syncytial Virus Infections, Severity of Illness Index. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background/Objective: Respiratory syncytial virus (RSV) is a major cause of bronchiolitis in infants and young children. Bronchiolitis, an acute inflammation of the lower respiratory tract, can lead to pneumonia, respiratory failure, and death. We aimed to compare the incidence and severity of RSV infection in children aged 0–60 months before and during the coronavirus disease 2019 (COVID‐19) pandemic.
Methods
A retrospective chart review was conducted on patients aged 0–60 months who tested positive for RSV between May 1, 2018, and May 31, 2022, in a community hospital in Queens County, New York City, United States. Comparisons were made between seasons 2018–2019 and 2019–2020 as before, and seasons 2020–2021 and 2021–2022 as during the COVID‐19 pandemic. Severity of RSV infection was assessed using the Bronchiolitis Severity Score (BSS). Data were analyzed using R software, a p value of < 0.05 was considered statistically significant.
Results
The incidence of RSV infection in seasons 2018–2019 and 2019–2020 peaked from mid‐October to February, whereas the first season during the COVID‐19 pandemic (2020–2021) was truncated with a very low incidence of RSV infection, and season 2021–2022 peaked from September to January, with the highest incidence (37%) and lower frequency of RSV infection at any given point. Patients during the season 2021–2022 were older ( H [2, 196.6] = 12.5, p < 0.001, 95% C I = [5.4, 25.6]) and had milder illness ( H [2, 187.5] = 7.5, p < 0.01, 95% C I = [2.1, 19.2]).
Conclusions
We observed a lower incidence of RSV infection and a lower rate of hospitalization for RSV during the COVID‐19 pandemic. The second RSV season during the COVID‐19 pandemic began earlier, lasted longer, and had a lower frequency. Older children with milder illnesses were affected most during this season. RSV epidemiology and disease burden were impacted by the COVID‐19 pandemic and could have significant ramifications for its prevention and control strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Flushing Hospital Medical Center, Flushing, New York 11355, USA.
- Department of Biology, Baylor University, Waco, Texas 76706, USA.
- Department of Research Education and Innovation, Medisys Health Network, Jamaica, New York 11418, USA.
ORCID-Profile: Andrew Miele, Lily Q Lew
Zitieren
APA
Trigueros Montes, J. B., Montes, D., Miele, A., Baik-Han, W., Gulati, G., & Lew, L. Q. (2024). The Impact of COVID‐19 Pandemic on Respiratory Syncytial Virus Infection in Children. Pulmonary Medicine, 2024(1). https://doi.org/10.1155/2024/2131098
Vancouver
Trigueros Montes JB, Montes D, Miele A, Baik-Han W, Gulati G, Lew LQ. The Impact of COVID‐19 Pandemic on Respiratory Syncytial Virus Infection in Children. Pulmonary Medicine. 2024;2024(1). doi:10.1155/2024/2131098
BibTeX
@article{TriguerosMontes2024,
author = {Trigueros Montes, Jose Boris and Montes, Diego and Miele, Andrew and Baik-Han, Won and Gulati, Gagan and Lew, Lily Q},
title = {The Impact of COVID‐19 Pandemic on Respiratory Syncytial Virus Infection in Children},
journal = {Pulmonary Medicine},
year = {2024},
volume = {2024},
number = {1},
doi = {10.1155/2024/2131098}
}
EUVIMED